These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16145181)

  • 1. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.
    Krell HV; Leuchter AF; Cook IA; Abrams M
    Psychosomatics; 2005; 46(5):379-84. PubMed ID: 16145181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reboxetine--another new antidepressant.
    Drug Ther Bull; 1998 Nov; 36(11):86-8. PubMed ID: 10562766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and antiepileptic drugs for chronic non-cancer pain.
    Maizels M; McCarberg B
    Am Fam Physician; 2005 Feb; 71(3):483-90. PubMed ID: 15712623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenaline in basic models of depression.
    Leonard BE
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S11-6; discussion S71-3. PubMed ID: 9169306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reboxetine (Edronax)].
    Souery D; Sternon J
    Rev Med Brux; 1999 Dec; 20(6):511-6. PubMed ID: 10672775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant therapy for unexplained symptoms and symptom syndromes.
    O'Malley PG; Jackson JL; Santoro J; Tomkins G; Balden E; Kroenke K
    J Fam Pract; 1999 Dec; 48(12):980-90. PubMed ID: 10628579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.
    Montgomery SA; Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for new and better antidepressants: reboxetine a new option.
    Dencker SJ
    Acta Psychiatr Scand Suppl; 2000; 402():6-11. PubMed ID: 10901153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
    Masana M; Castañé A; Santana N; Bortolozzi A; Artigas F
    Neuropharmacology; 2012 Sep; 63(4):675-84. PubMed ID: 22652058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SSRI resistant depression. Supplementation with noradrenergic pharmaceuticals can be a good alternative].
    Bodlund O; Häggström L
    Lakartidningen; 2004 Sep; 101(36):2712-4. PubMed ID: 15455633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reboxetine: a review of antidepressant tolerability.
    Mucci M
    J Psychopharmacol; 1997; 11(4 Suppl):S33-7. PubMed ID: 9438231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reboxetine for the treatment of patients with Cocaine Dependence Disorder.
    Szerman N; Peris L; Mesías B; Colis P; Rosa J; Prieto A;
    Hum Psychopharmacol; 2005 Apr; 20(3):189-92. PubMed ID: 15799010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial.
    Golubchik P; Sever J; Weizman A
    Clin Neuropharmacol; 2013; 36(2):37-41. PubMed ID: 23503544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of reboxetine in bulimia nervosa: a pilot study.
    Fassino S; Daga GA; Boggio S; Garzaro L; Pierò A
    J Psychopharmacol; 2004 Sep; 18(3):423-8. PubMed ID: 15358988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking the pain out of depression: dual action antidepressants in the relief of pain in depression, fibromyalgia and other chronic pain syndromes.
    Wessely S; Hindmarch I
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S1-2. PubMed ID: 15378671
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain.
    Katz J; Pennella-Vaughan J; Hetzel RD; Kanazi GE; Dworkin RH
    J Pain; 2005 Oct; 6(10):656-61. PubMed ID: 16202958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do antidepressant medications relieve chronic low back pain?
    Turner JA; Denny MC
    J Fam Pract; 1993 Dec; 37(6):545-53. PubMed ID: 8245805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chairman's overview. The place of reboxetine in antidepressant therapy.
    Montgomery SA
    J Clin Psychiatry; 1998; 59 Suppl 14():26-9. PubMed ID: 9818628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O; Hetzel G; Michael N; Rothermundt M; Arolt V; Erfurth A
    Neuropsychobiology; 2005; 51(2):67-71. PubMed ID: 15741746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.